<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Studies of blood fibrinolytic activity in 112 patients with repeated <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> or injury to the myocardium have revealed reduced fibrinolytic activity on non-heated fibrin plates, decreased plasmin activity and euglobulin+ fraction lysis, lowered levels of plasminogen activator, total nonenzymic fibrinolysis, antithrombin III, ++FFDP, and elevated soluble complexes of fibrin-monomer level </plain></SENT>
<SENT sid="1" pm="."><plain>Complications of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> presenting as <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>; ciliary <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002617'>aneurysm</z:hpo> with <z:mp ids='MP_0005048'>thrombosis</z:mp> are associated with still more marked disorders of the fibrinolysis system </plain></SENT>
</text></document>